Cue Biopharma, Inc. (CUE)
NasdaqCM • Currently up 3.58 (+15.44%) in today's trading session
1 member of Congress has disclosed 1 trade in Cue Biopharma, Inc. (CUE) via STOCK Act filings. The most recent disclosure was filed by Diana Harshbarger on 25 April 2022.
Cue Biopharma, Inc. is currently trading at $26.76, positioned at 54% of its 52-week range ($4.98 – $45.50).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Past Performance is not an indication of future results.
Current Price
$26.76
24h Change
+3.58 (+15.44%)
52 Week Range
$4.98—$45.50
Cue Biopharma, Inc. Price History and Technical Analysis
Interactive Chart
Congressional Trading Activity for CUE
Select to highlight on chart
1 transactions
Compliance: 100%
| Diana Harshbarger | 25 Apr 2022 | N/A | Stock | N/A |
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations
Frequently Asked Questions about CUE
- Which members of Congress have traded CUE?
- 1 member of Congress has disclosed 1 trade in Cue Biopharma, Inc. (CUE) under the STOCK Act: Diana Harshbarger.
- When was CUE most recently disclosed by Congress?
- The most recent CUE disclosure was filed by Diana Harshbarger on 25 April 2022.
- How can I track new congressional trades in CUE?
- This CUE page updates as soon as new STOCK Act disclosures are filed for Cue Biopharma, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track CUE in Congress
See when politicians buy or sell this stock